The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. TherapeuticsMD Inc shares valued at $14,031 were purchased by Thompson Tommy G on Dec 23 ’25. At $1.67 per share, Thompson Tommy G acquired 8,400 shares. The insider’s holdings grew to 23,179 shares worth approximately $37781.77 following the completion of this transaction.
Also, Thompson Tommy G purchased 325 shares, netting a total of over 326 in proceeds. Following the buying of shares at $1.00 each, the insider now holds 14,779 shares.
Before that, Walker Marlan D had added 490 shares to its account. In a trade valued at $489, the Chief Executive Officer bought TherapeuticsMD Inc shares for $1.00 each. Upon closing the transaction, the insider’s holdings increased to 490 shares, worth approximately $0.12 million.
As published in a research note from Jefferies on August 07, 2020, TherapeuticsMD Inc [TXMD] has been rated down from a Hold to an Underperform. Analysts at JP Morgan downgraded the stock from ‘”an Overweight”‘ to ‘”a Neutral”‘ outlook in a report released in mid May. As of December 02, 2019, Guggenheim has initiated its “Buy” rating for TXMD. Earlier on October 17, 2019, H.C. Wainwright initiated its rating. Their recommendation was “a Buy” for TXMD stock.
Analyzing TXMD Stock Performance
On last trading session, TherapeuticsMD Inc [NASDAQ: TXMD] plunged -0.61% to $1.63. The stock’s lowest price that day was $1.6, but it reached a high of $1.69 in the same session. During the last five days, there has been a drop of approximately -0.61%. Over the course of the year, TherapeuticsMD Inc shares have jumped approximately 49.54%. Shares of the company reached a 52-week high of $2.4400 on 01/03/25 and a 52-week low of $0.7200 on 03/14/25.
Support And Resistance Levels for TherapeuticsMD Inc (TXMD)
According to the 24-hour chart, there is a support level at 1.5900, which, if violated, would cause prices to drop to 1.5500. In the upper region, resistance lies at 1.6800. The next price resistance is at 1.7300. RSI (Relative Strength Index) is 49.16 on the 14-day chart, showing neutral technical sentiment.
Is TherapeuticsMD Inc subject to short interest?
Stocks of TherapeuticsMD Inc saw a sharp steep in short interest on 2025-12-15 dropping by 2107.0 shares to 67400.0. Data from Yahoo Finance shows that the short interest on 2025-11-14 was 69507.0 shares. A decline of -3.13% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 0.59 of the overall float, the days-to-cover ratio (short ratio) decline to 0.59.
